Víctor Pérez

Research interests

Publications

• Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial

  BMC Psychiatry · 2017 · https://doi.org/10.1186/s12888-017-1412-1

• Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia

  Psychiatry Research · 2010 · https://doi.org/10.1016/j.psychres.2009.05.004

• Dialectical behaviour therapy skills training compared to standard group therapy in borderline personality disorder: A 3-month randomised controlled clinical trial

  Behaviour Research and Therapy · 2009 · https://doi.org/10.1016/j.brat.2009.01.013

• Oxidative damage–induced inflammation initiates age-related macular degeneration

  Nature Medicine · 2008 · https://doi.org/10.1038/nm1709

• Suicide methods in Europe: a gender-specific analysis of countries participating in the “European Alliance Against Depression”

  Journal of Epidemiology & Community Health · 2008 · https://doi.org/10.1136/jech.2007.065391

• Health Care Access, Use of Services, and Experiences Among Undocumented Mexicans and Other Latinos

  Archives of Internal Medicine · 2007 · https://doi.org/10.1001/archinte.167.21.2354

• Induction of Peripheral T Cell Tolerance In Vivo Requires CTLA-4 Engagement

  Immunity · 1997 · https://doi.org/10.1016/s1074-7613(00)80284-8

• Fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients

  Journal of Sex & Marital Therapy · 1997 · https://doi.org/10.1080/00926239708403923

• Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment

  The Lancet · 1997 · https://doi.org/10.1016/s0140-6736(96)08007-5

Current projects

No projects listed.